vs
Consensus Cloud Solutions, Inc.(CCSI)与Cytek Biosciences, Inc.(CTKB)财务数据对比。点击上方公司名可切换其他公司
Consensus Cloud Solutions, Inc.的季度营收约是Cytek Biosciences, Inc.的1.4倍($88.5M vs $62.1M),Consensus Cloud Solutions, Inc.净利率更高(27.9% vs -70.9%,领先98.8%),Cytek Biosciences, Inc.同比增速更快(8.1% vs 1.5%),Consensus Cloud Solutions, Inc.自由现金流更多($38.5M vs $-1.8M),过去两年Cytek Biosciences, Inc.的营收复合增速更高(17.7% vs 0.6%)
Consensus Cloud Solutions是一家云解决方案提供商,核心产品包括加密数字传真、安全文档交换、工作流程自动化工具,主要面向医疗、法律、金融服务等领域的北美企业客户提供相关服务。
Cytek Biosciences主营高性能流式细胞分析系统、配套试剂及分析软件的研发、生产与商业化,产品服务覆盖生命科学研究、临床诊断、生物制药开发等领域,客户遍及全球多个主要地区。
CCSI vs CTKB — 直观对比
营收规模更大
CCSI
是对方的1.4倍
$62.1M
营收增速更快
CTKB
高出6.6%
1.5%
净利率更高
CCSI
高出98.8%
-70.9%
自由现金流更多
CCSI
多$40.2M
$-1.8M
两年增速更快
CTKB
近两年复合增速
0.6%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $88.5M | $62.1M |
| 净利润 | $24.7M | $-44.1M |
| 毛利率 | 80.9% | 52.9% |
| 营业利润率 | 42.7% | -9.0% |
| 净利率 | 27.9% | -70.9% |
| 营收同比 | 1.5% | 8.1% |
| 净利润同比 | 16.7% | -557.1% |
| 每股收益(稀释后) | $1.30 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
CCSI
CTKB
| Q1 26 | $88.5M | — | ||
| Q4 25 | $87.1M | $62.1M | ||
| Q3 25 | $87.8M | $52.3M | ||
| Q2 25 | $87.7M | $45.6M | ||
| Q1 25 | $87.1M | $41.5M | ||
| Q4 24 | $87.0M | $57.5M | ||
| Q3 24 | $87.8M | $51.5M | ||
| Q2 24 | $87.5M | $46.6M |
净利润
CCSI
CTKB
| Q1 26 | $24.7M | — | ||
| Q4 25 | $20.5M | $-44.1M | ||
| Q3 25 | $22.1M | $-5.5M | ||
| Q2 25 | $20.8M | $-5.6M | ||
| Q1 25 | $21.2M | $-11.4M | ||
| Q4 24 | $18.1M | $9.6M | ||
| Q3 24 | $21.1M | $941.0K | ||
| Q2 24 | $23.9M | $-10.4M |
毛利率
CCSI
CTKB
| Q1 26 | 80.9% | — | ||
| Q4 25 | 80.0% | 52.9% | ||
| Q3 25 | 80.0% | 52.7% | ||
| Q2 25 | 79.9% | 52.3% | ||
| Q1 25 | 79.3% | 48.6% | ||
| Q4 24 | 79.5% | 58.5% | ||
| Q3 24 | 79.9% | 56.3% | ||
| Q2 24 | 80.4% | 54.6% |
营业利润率
CCSI
CTKB
| Q1 26 | 42.7% | — | ||
| Q4 25 | 41.1% | -9.0% | ||
| Q3 25 | 43.2% | -17.6% | ||
| Q2 25 | 44.5% | -23.3% | ||
| Q1 25 | 43.0% | -36.1% | ||
| Q4 24 | 38.4% | 5.2% | ||
| Q3 24 | 43.8% | -8.2% | ||
| Q2 24 | 45.6% | -18.3% |
净利率
CCSI
CTKB
| Q1 26 | 27.9% | — | ||
| Q4 25 | 23.5% | -70.9% | ||
| Q3 25 | 25.2% | -10.5% | ||
| Q2 25 | 23.7% | -12.2% | ||
| Q1 25 | 24.3% | -27.5% | ||
| Q4 24 | 20.8% | 16.8% | ||
| Q3 24 | 24.1% | 1.8% | ||
| Q2 24 | 27.3% | -22.4% |
每股收益(稀释后)
CCSI
CTKB
| Q1 26 | $1.30 | — | ||
| Q4 25 | $1.06 | — | ||
| Q3 25 | $1.15 | — | ||
| Q2 25 | $1.07 | — | ||
| Q1 25 | $1.07 | — | ||
| Q4 24 | $0.92 | — | ||
| Q3 24 | $1.09 | — | ||
| Q2 24 | $1.24 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $92.3M | $90.9M |
| 总债务越低越好 | $556.8M | — |
| 股东权益账面价值 | $22.0M | $341.7M |
| 总资产 | $678.7M | $461.5M |
| 负债/权益比越低杠杆越低 | 25.31× | — |
8季度趋势,按日历期对齐
现金及短期投资
CCSI
CTKB
| Q1 26 | $92.3M | — | ||
| Q4 25 | $74.7M | $90.9M | ||
| Q3 25 | $97.6M | $93.3M | ||
| Q2 25 | $57.9M | $75.5M | ||
| Q1 25 | $53.4M | $95.3M | ||
| Q4 24 | $33.5M | $98.7M | ||
| Q3 24 | $54.6M | $162.3M | ||
| Q2 24 | $49.2M | $177.9M |
总债务
CCSI
CTKB
| Q1 26 | $556.8M | — | ||
| Q4 25 | $558.4M | — | ||
| Q3 25 | $578.6M | — | ||
| Q2 25 | $578.2M | — | ||
| Q1 25 | $583.7M | — | ||
| Q4 24 | $593.0M | — | ||
| Q3 24 | $612.5M | — | ||
| Q2 24 | $642.8M | — |
股东权益
CCSI
CTKB
| Q1 26 | $22.0M | — | ||
| Q4 25 | $13.8M | $341.7M | ||
| Q3 25 | $-2.6M | $378.6M | ||
| Q2 25 | $-26.5M | $377.6M | ||
| Q1 25 | $-49.4M | $379.6M | ||
| Q4 24 | $-79.5M | $395.7M | ||
| Q3 24 | $-93.2M | $385.5M | ||
| Q2 24 | $-124.4M | $389.1M |
总资产
CCSI
CTKB
| Q1 26 | $678.7M | — | ||
| Q4 25 | $663.8M | $461.5M | ||
| Q3 25 | $675.0M | $494.9M | ||
| Q2 25 | $641.5M | $493.3M | ||
| Q1 25 | $629.6M | $482.6M | ||
| Q4 24 | $602.2M | $499.5M | ||
| Q3 24 | $622.5M | $491.2M | ||
| Q2 24 | $608.5M | $483.7M |
负债/权益比
CCSI
CTKB
| Q1 26 | 25.31× | — | ||
| Q4 25 | 40.54× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $45.8M | $-771.0K |
| 自由现金流经营现金流 - 资本支出 | $38.5M | $-1.8M |
| 自由现金流率自由现金流/营收 | 43.5% | -2.9% |
| 资本支出强度资本支出/营收 | — | 1.6% |
| 现金转化率经营现金流/净利润 | 1.86× | — |
| 过去12个月自由现金流最近4个季度 | $110.6M | $-8.8M |
8季度趋势,按日历期对齐
经营现金流
CCSI
CTKB
| Q1 26 | $45.8M | — | ||
| Q4 25 | $15.2M | $-771.0K | ||
| Q3 25 | $51.6M | $-3.9M | ||
| Q2 25 | $28.3M | $108.0K | ||
| Q1 25 | $40.9M | $-125.0K | ||
| Q4 24 | $11.1M | $2.0M | ||
| Q3 24 | $41.6M | $13.2M | ||
| Q2 24 | $24.4M | $6.2M |
自由现金流
CCSI
CTKB
| Q1 26 | $38.5M | — | ||
| Q4 25 | $7.3M | $-1.8M | ||
| Q3 25 | $44.4M | $-4.6M | ||
| Q2 25 | $20.3M | $-1.5M | ||
| Q1 25 | $33.7M | $-974.0K | ||
| Q4 24 | $3.1M | $1.1M | ||
| Q3 24 | $33.6M | $12.2M | ||
| Q2 24 | $15.8M | $5.2M |
自由现金流率
CCSI
CTKB
| Q1 26 | 43.5% | — | ||
| Q4 25 | 8.4% | -2.9% | ||
| Q3 25 | 50.6% | -8.7% | ||
| Q2 25 | 23.2% | -3.2% | ||
| Q1 25 | 38.7% | -2.3% | ||
| Q4 24 | 3.6% | 1.9% | ||
| Q3 24 | 38.3% | 23.7% | ||
| Q2 24 | 18.1% | 11.0% |
资本支出强度
CCSI
CTKB
| Q1 26 | — | — | ||
| Q4 25 | 9.1% | 1.6% | ||
| Q3 25 | 8.2% | 1.3% | ||
| Q2 25 | 9.1% | 3.5% | ||
| Q1 25 | 8.3% | 2.0% | ||
| Q4 24 | 9.2% | 1.6% | ||
| Q3 24 | 9.1% | 2.0% | ||
| Q2 24 | 9.8% | 2.3% |
现金转化率
CCSI
CTKB
| Q1 26 | 1.86× | — | ||
| Q4 25 | 0.74× | — | ||
| Q3 25 | 2.34× | — | ||
| Q2 25 | 1.36× | — | ||
| Q1 25 | 1.94× | — | ||
| Q4 24 | 0.62× | 0.21× | ||
| Q3 24 | 1.97× | 14.05× | ||
| Q2 24 | 1.02× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CCSI
暂无分部数据
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |